The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
Open accessAbstract
Tumor hypoxia is a well-established biological phenomenon that affects the curability of solid tumors, regardless of treatment modality. Especially for head and neck cancer patients, tumor hypoxia is linked to poor patient outcomes. Given the biological problems associated with tumor hypoxia, the goal for clinicians has been to identify moderately to severely hypoxic tumors for differential treatment strategies. The “gold standard” for detecting and characterizing of tumor hypoxia are the invasive polarographic electrodes. Several less invasive hypoxia assessment techniques have also shown promise for hypoxia assessment. The widespread incorporation of hypoxia information in clinical tumor assessment is severely impeded by several factors, including regulatory hurdles and unclear correlation with potential treatment decisions. There is now an acute need for approved diagnostic technologies for determining the hypoxia status of cancer lesions, as it would enable clinical development of personalized, hypoxia-based therapies, which will ultimately improve outcomes. A number of different techniques for assessing tumor hypoxia have evolved to replace polarographic pO2 measurements for assessing tumor hypoxia. Several of these modalities, either individually or in combination with other imaging techniques, provide functional and physiological information of tumor hypoxia that can significantly improve the course of treatment. The assessment of tumor hypoxia will be valuable to radiation oncologists, surgeons, and biotechnology and pharmaceutical companies who are engaged in developing hypoxia-based therapies or treatment strategies. Antioxid. Redox Signal. 21, 1516–1554. I. Introduction II. The Clinical Importance of Tumor Hypoxia A. Pathophysiology of hypoxia B. Hypoxia's negative impact on the effectiveness of curative treatment 1. Hypoxic tumors accumulate and propagate cancer stem cells 2. Hypoxia reduces the effectiveness of radiotherapy 3. Hypoxia increases metastasis risk and reduces the effectiveness of surgery 4. Hypoxic tumors are resistant to the effects of chemotherapy and chemoradiation C. Hypoxia is prognostic for poor patient outcomes III. Diagnosis of Tumor Hypoxia A. Direct methods 1. Oxygen electrode—direct pO2 measurement most used in cancer research 2. Phosphorescence quenching—alternative direct pO2 measurement 3. Electron paramagnetic resonance 4. 19F-magnetic resonance spectroscopy 5. Overhauser-enhanced MRI B. Endogenous markers of hypoxia 1. Hypoxia-inducible factor-1α 2. Carbonic anhydrase IX 3. Glucose transporter 1 4. Osteopontin 5. A combined IHC panel of protein markers for hypoxia 6. Comet assay C. Physiologic methods 1. Near-infrared spectroscopy/tomography—widely used for pulse oximetry 2. Photoacoustic tomography 3. Contrast-enhanced color duplex sonography 4. MRI-based measurements 5. Blood oxygen level-dependent MRI 6. Pimonidazole 7. EF5 (pentafluorinated etanidazole) 8. Hypoxia PET imaging—physiologic hypoxia measurement providing tomographic information a. 18F-fluoromisonidazole b. 18F-fluoroazomycinarabinofuranoside c. 18F-EF5 (pentafluorinated etanidazole) d. 18F-flortanidazole e. Copper (II) (diacetyl-bis (N4-methylthiosemicarbazone)) f. 18F-FDG imaging of hypoxia IV. Modifying Hypoxia to Improve Therapeutic Outcomes A. Use of hypoxia information in radiation therapy planning B. Use of hypoxia assessment for selection of patients responsive to nimorazole C. Use of hypoxia assessment for selection of patients responsive to tirapazamine D. Use of hypoxia assessment for selection of patients responsive to oxygen delivery therapies V. Concluding Remarks
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–274 of 274
A New Method for Measuring Oxygen Concentration in Biological Systems
Vanderkooi, J. M., & Wilson, D. F. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5188-7_25 · Cited by 81
In vivo photoacoustic lifetime imaging of tumor hypoxia in small animals
Shao, Q., Morgounova, E., Jiang, C., Choi, J., Bischof, J. C., & Ashkenazi, S. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.18.7.076019 · Cited by 80
Mortensen, L. S., Buus, S., Nordsmark, M., Bentzen, L., Munk, O. L., Keiding, S., & Overgaard, J. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.516274 · Cited by 79
Immunohistochemical Detection of Changes in Tumor Hypoxia
Russell, J., Carlin, S., Burke, S. A., Wen, B., Yang, K., & Ling, C. C. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.004 · Cited by 79
Tran, L. B. A., Bol, A., Labar, D., Jordan, B. F., Magat, J., Mignion, L., Grégoire, V., & Gallez, B. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.04.011 · Cited by 78
Donaldson, S. B., Betts, G. N. J., Bonington, S. C., Homer, J. J., Slevin, N. J., Kershaw, L. E., Valentine, H. R., West, C., & Buckley, D. L. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.039 · Cited by 77
Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.
Holland, J. P., Lewis, J. S., & Dehdashti, F. (2009) · PubMed · Cited by 76
Lawrence, Y. R., Vikram, B., Dignam, J. J., Chakravarti, A., Machtay, M. X., Freidlin, B., Takebe, N., Curran, W. J., Bentzen, S. M., Okunieff, P. G., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs472 · Cited by 74
Gagel, B., Piroth, M. D., Pinkawa, M., Reinartz, P., Zimny, M., Kaiser, H. J., Stanzel, S. F., Asadpour, B., Demirel, C., Hamacher, K., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-113 · Cited by 73
Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer
Zhu, Y., Denhardt, D. T., Cao, H., Sutphin, P. D., Koong, A. C., Giaccia, A. J., & Le, Q. (2005) · Oncogene · doi:10.1038/sj.onc.1208800 · Cited by 71
Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies.
Graham, M. M., Peterson, L. M., Link, J. M., et al. (1997) · PubMed · Cited by 68
Kiéda, C., Hafny‐Rahbi, B. E., Collet, G., Lamerant‐Fayel, N., Grillon, C., Guichard, A., Dulak, J., Józkowicz, A., Kotlinowski, J., Fylaktakidou, K. C., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0992-6 · Cited by 68
The cancer biomarker osteopontin: combination with other markers.
Weber, G. F. (2011) · PubMed · Cited by 66
Koch, C. J., Scheuermann, J. S., Divgi, C. R., Judy, K. D., Kachur, A. V., Freifelder, R. H., Reddin, J. S., Karp, J. S., Stubbs, J. B., Hahn, S. M., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1517-y · Cited by 66
Wang, J., Foehrenbacher, A., Su, J., Patel, R., Hay, M. P., Hicks, K. O., & Wilson, W. R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2296 · Cited by 66
Koch, C. J., Hahn, S. M., Rockwell, K., Covey, J. M., McKenna, W. G., & Evans, S. M. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100324 · Cited by 65
EPR Oxygen Images Predict Tumor Control by a 50% Tumor Control Radiation Dose
Elas, M., Magwood, J. M., Butler, B., Li, C., Wardak, R., DeVries, R., Barth, E. D., Epel, B., Rubinstein, S. M., Pelizzari, C. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0069 · Cited by 65
Bache, M., Reddemann, R., Said, H. M., Holzhausen, H.-J., Taubert, H. W., Becker, A., Kuhnt, T., Hänsgen, G., Dunst, J., & Vordermark, D. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.1376 · Cited by 64
Marotta, D. E., Karar, J., Jenkins, W. T., Kumanova, M., Jenkins, K. W., Tobias, J. W., Baldwin, D. A., Hatzigeorgiou, A. G., Alexiou, P., Evans, S. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3061 · Cited by 62
Clark, L. C., Ackerman, J. L., Thomas, S. R., Millard, R. W., Hoffman, R. E., Pratt, R. G., Ragle-Cole, H., Kinsey, R. A., & Janakiraman, R. (1984) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-4895-5_81 · Cited by 61
Hypoxia and VEGF mRNA Expression in Human Tumors
Ziemer, L. S., Koch, C. J., Maity, A. M., Magarelli, D. P., Horan, A. D., & Evans, S. M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900195 · Cited by 60
Tanaka, N., Kato, H., Inose, T., Kimura, H., Faried, A., Sohda, M., Nakajima, M., Fukai, Y., Miyazaki, T., Masuda, N., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604719 · Cited by 59
Pathophysiology of Solid Tumors
Vaupel, P. W. (2009) · Medical radiology · doi:10.1007/978-3-540-74386-6_4 · Cited by 59
EF5 binding and clinical outcome in human soft tissue sarcomas
Evans, S. M., Fraker, D. L., Hahn, S. M., Gleason, K., Jenkins, W. T., Jenkins, K. W., Hwang, W., Zhang, P. J., Mick, R., & Koch, C. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.068 · Cited by 58
Le, Q., Taira, A. V., Budenz, S., Dorie, M. J., Goffinet, D. R., Fee, W. E., Goode, R. L., Bloch, D. A., Koong, A. C., Brown, J. M., et al. (2006) · Cancer · doi:10.1002/cncr.21785 · Cited by 58
Eriksen, J. G., & Overgaard, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.009 · Cited by 58
Dische, S., Chassagne, D., Hope-Stone, H. F., Dawes, P. J. D., Roberts, J. T., Yosef, H., Bey, P., Horiot, J. C., Jacobson, A., Frankendal, B., et al. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90089-q · Cited by 58
Bowen, S. R., van der Kogel, A. J., Nordsmark, M., Bentzen, S. M., & Jeraj, R. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.02.002 · Cited by 56
Evans, S. M., Du, K. L., Chalian, A. A., Mick, R., Zhang, P. J., Hahn, S. M., Quon, H., Lustig, R. A., Weinstein, G. S., & Koch, C. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.067 · Cited by 56
Parra, R. G., Wood, D. P., Shah, R. B., Siddiqui, J., Hussain, H. K., Park, H., Desmond, T. J., Meyer, C. R., & Piert, M. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1876-z · Cited by 55
A comparison in individual murine tumors of techniques for measuring oxygen levels
Kavanagh, M.-C., Tsang, V., Chow, S., Koch, C. J., Hedley, D. W., Minkin, S., & Hill, R. P. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00104-2 · Cited by 55
Clinical Electron Paramagnetic Resonance (EPR) Oximetry Using India Ink
Williams, B. B., Khan, N. I., Zaki, B. I., et al. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1241-1_21 · Cited by 53
Valable, S., Petit, E., Roussel, S., Marteau, L., Toutain, J., Divoux, D., Sobrio, F., Delamare, J., Barré, L., & Bernaudin, M. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.01.010 · Cited by 53
Evans, S. M., Jenkins, K. W., Chen, H. I., Jenkins, W. T., Judy, K. D., Hwang, W., Lustig, R. A., Judkins, A. R., Gradyt, M. S., Hahn, S. M., et al. (2010) · Translational Oncology · doi:10.1593/tlo.09265 · Cited by 53
Doss, M., Zhang, J., Bélanger, M.-J., Stubbs, J. B., Hostetler, E. D., Alpaugh, K. R., Kolb, H. C., & Yu, J. Q. (2010) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283407950 · Cited by 52
Self-citationWarner, A. B., Rabbani, Z. N., Hardee, M. E., Kim, S. J., Broadwater, G., Bentley, R. C., Snyder, S. A., Vujaskovic, Z., Oosterwijk, E., Harris, L. N., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.32 · Cited by 51
Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor
Bourke, V. A., Zhao, D., Gilio, J. P., Chang, C.-H., Jiang, L., Hahn, E. W., & Mason, R. P. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.037 · Cited by 49
Bollineni, V. R., Wiegman, E. M., Pruim, J., Groen, H. J. M., & Langendijk, J. A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.003 · Cited by 47
Brockton, N. T., Dort, J. C., Lau, H., Hao, D., Brar, S., Klimowicz, A. C., Petrillo, S. K., Diaz, R., Doll, C., & Magliocco, A. M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.059 · Cited by 47
Kappler, M., Taubert, H. W., Holzhausen, H.-J., Reddemann, R., Rot, S., Becker, A., Kuhnt, T., Dellas, K., Dunst, J., Vordermark, D., et al. (2008) · Strahlentherapie und Onkologie · doi:10.1007/s00066-008-1813-7 · Cited by 47
Collet, G., Skrzypek, K., Grillon, C., Matejuk, A., Hafny‐Rahbi, B. E., Lamerant‐Fayel, N., & Kiéda, C. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.03.001 · Cited by 46
Mortensen, L. S., Busk, M., Nordsmark, M., Jakobsen, S., Theil, J., Overgaard, J., & Horsman, M. R. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.034 · Cited by 46
Le, Q., Kovacs, M. S., Dorie, M. J., Koong, A. C., Terris, D. J., Pinto, H. A., Goffinet, D. R., Nowels, K. W., Bloch, D. A., & Brown, J. M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04503-0 · Cited by 43
Havelund, B. M., Holdgaard, P. C., Rafaelsen, S. R., Mortensen, L. S., Theil, J., Bender, D., Pløen, J., Spindler, K. G., & Jakobsen, A. K. M. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32835bd5bc · Cited by 43
Development of a hybrid EPR/NMR coimaging system
Samouilov, A., Caia, G. L., Kesselring, E., Petryakov, S. V., Wąsowicz, T. J., & Zweier, J. L. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21205 · Cited by 42
Advances in methods for assessing tumor hypoxia in vivo: Implications for treatment planning
Davda, S., & Bezabeh, T. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9009-z · Cited by 42
Mahy, P., Bast, M. D., Gallez, B., Gueulette, J., Koch, C. J., Scalliet, P. G. M., & Grégoire, V. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00028-8 · Cited by 42
Novel radiation sensitizers targeting tissue hypoxia.
Ravaud, A., Borner, M., Schellens, J. H. M., Geoffrois, L., Schöffski, P., Wanders, J., & Hanauske, A. R. (1999) · PubMed · Cited by 42
Nyflot, M. J., Harari, P. M., Yip, S. S. F., Perlman, S. B., & Jeraj, R. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.09.012 · Cited by 41
Lee, C. P., Payne, G. S., Oregioni, A., Ruddle, R. R., Tan, S., Raynaud, F. I., Eaton, D., Campbell, M. J., Cross, K., Halbert, G., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605425 · Cited by 41
Cerebral tissue oxygenation measured by two different probes: challenges and interpretation
Dengler, J., Frenzel, C., Vajkoczy, P., Wolf, S., & Horn, P. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2316-z · Cited by 41
Lee, D.-J., Pajak, T. F., Stetz, J., Order, S. E., Weissberg, J. B., & Fischer, J. J. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90343-x · Cited by 41
Hypoxia in human intraperitoneal and extremity sarcomas
Evans, S. M., Hahn, S. M., Magarelli, D. P., Zhang, P. J., Jenkins, W. T., Fraker, D. L., Hsi, R. A., McKenna, W. G., & Koch, C. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01494-2 · Cited by 41
Rischin, D., Fisher, R., Peters, L., Corry, J. F., & Hicks, R. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.05.043 · Cited by 40
Imaging of Hypoxia Using PET and MRI
Gaertner, F. C., Souvatzoglou, M., Brix, G., & Beer, A. J. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112799436267 · Cited by 40
Plasma Osteopontin, Hypoxia, and Response to Radiotherapy in Nasopharyngeal Cancer
Hui, E. P., Sung, F. L., Yu, B. K. H., Wong, S. C. C., Ma, B. B. Y., Lin, X., Chan, A. M.-L., Wong, W.-L., & Chan, A. T. �. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0364 · Cited by 38
Woods, M. L., Koch, C. J., & Lord, E. M. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02006-3 · Cited by 36
Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia
Aquino‐Parsons, C., Luo, C., Vikse, C. M., & Olive, P. L. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00035-3 · Cited by 35
Scholbach, T., Scholbach, J., Krombach, G. A., Gagel, B., Maneschi, P., & Martino, E. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.20827 · Cited by 35
Dai, N., Bao, Q., Lu, A., & Li, J. (2007) · Oncology · doi:10.1159/000111108 · Cited by 35
Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts
Gaustad, J., Simonsen, T. G., Leinaas, M. N., & Rofstad, E. K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-388 · Cited by 35
Li, S. P., Padhani, A. R., & Makris, A. (2011) · JNCI Monographs · doi:10.1093/jncimonographs/lgr031 · Cited by 35
Dietz, A., Vanselow, B., Rudat, V., Conradt, C., Weidauer, H., Kallinowski, F., & Dollner, R. (2002) · Head & Neck · doi:10.1002/hed.10177 · Cited by 33
Eichhorn, M., Strieth, S., Luedemann, S., Kleespies, A., Nöth, U., Passon, A., Brix, G., Jauch, K. ‐., Bruns, C. J., & Dellian, M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.5997 · Cited by 28
Khan, N. I., Mupparaju, S. P., Hou, H. G., Williams, B. B., & Swartz, H. M. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.10.026 · Cited by 28
Head and Neck Cancer: The Importance of Oxygen
Terris, D. J. (2000) · The Laryngoscope · doi:10.1097/00005537-200005000-00001 · Cited by 28
Clinical trials with etanidazole (SR-2508) by the radiation therapy oncology group (RTOG)
Wasserman, T. H., Lee, D. J., Cosmatos, D., Coleman, C. N., Phillips, T. L., Davis, L. W., Marcial, V. A., & Stetz, J. (1991) · Radiotherapy and Oncology · doi:10.1016/0167-8140(91)90200-z · Cited by 25
Danhier, F., Danhier, P., Magotteaux, N., Preter, G. D., Učakar, B., Karroum, O., Jordan, B. F., Gallez, B., & Véronique Préat, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040772 · Cited by 22
Radiation Dosimetry and Biodistribution of the Hypoxia Tracer 18 F-EF5 in Oncologic Patients
Lin, L. L., Silvoniemi, A., Stubbs, J. B., Rengan, R., Suilamo, S., Solin, O. H., Divgi, C. R., Eskola, O., Sorger, J., Stabin, M. G., et al. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.1130 · Cited by 20
The effect of bleomycin on aerated and hypoxic cells in vitro, in combination with irradiation
Roizin-Towle, L., & Hall, E. J. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90756-9 · Cited by 18
Implementation of hypoxia measurement into lung cancer therapy
Meng, X., Kong, F., & Yu, J. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.09.009 · Cited by 17
Elusive Goal of Targeting Tumor Hypoxia for Therapeutic Gain
Peters, L., & Rischin, D. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8294 · Cited by 17
Oxygen Pressures in the Interstitial Space of Skeletal Muscle and Tumors in vivo
Wilson, D. F., Lee, W. M. F., Makonnen, S., Apreleva, S., & Vinogradov, S. A. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74911-2_7 · Cited by 15
Evaluation of tumor oxygenation by color duplex sonography: A new approach
Martino, E. F. N. D., Gagel, B., Schramm, O., Maneschi, P., & Westhofen, M. (2005) · Otolaryngology · doi:10.1016/j.otohns.2005.01.033 · Cited by 11
Cited by
ESPEN expert group recommendations for action against cancer-related malnutrition
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E. P., Erickson, N., Laviano, A., Lisanti, M. P., Lobo, D. N., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.017 · Cited by 1,305
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
HIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Molecular imaging of the tumor microenvironment
Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253
Tumor hypoxia: From basic knowledge to therapeutic implications
Liao, C., Liu, X., Zhang, C., & Zhang, Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.011 · Cited by 223
Metadata
- Authors
- Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2014-10
- Volume
- 21
- Issue
- 10
- Pages
- 1516-1554
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2132719707
- Cited by
- 420
- References
- 274
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.